ALPS Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Sell |
78,356
-33,019
| -30% | -$462K | 0.01% | 484 |
|
|
2025
Q1 | $1.51M | Sell |
111,375
-5,002
| -4% | -$68K | 0.01% | 388 |
|
|
2024
Q4 | $2.37M | Buy |
116,377
+10,130
| +10% | +$206K | 0.02% | 320 |
|
|
2024
Q3 | $3.09M | Sell |
106,247
-4,992
| -4% | -$145K | 0.02% | 291 |
|
|
2024
Q2 | $2.58M | Buy |
111,239
+13,090
| +13% | +$304K | 0.02% | 305 |
|
|
2024
Q1 | $2.01M | Buy |
98,149
+187
| +0.2% | +$3.84K | 0.01% | 348 |
|
|
2023
Q4 | $2.1M | Sell |
97,962
-3,438
| -3% | -$73.8K | 0.02% | 324 |
|
|
2023
Q3 | $2.09M | Buy |
101,400
+780
| +0.8% | +$16.1K | 0.02% | 314 |
|
|
2023
Q2 | $2.97M | Buy |
100,620
+10,575
| +12% | +$312K | 0.03% | 250 |
|
|
2023
Q1 | $2.07M | Sell |
90,045
-1,984
| -2% | -$45.7K | 0.02% | 283 |
|
|
2022
Q4 | $2.56M | Buy |
92,029
+24,706
| +37% | +$687K | 0.02% | 256 |
|
|
2022
Q3 | $2.07M | Sell |
67,323
-5,617
| -8% | -$172K | 0.02% | 304 |
|
|
2022
Q2 | $2.15M | Buy |
+72,940
| New | +$2.15M | 0.02% | 308 |
|